Market Overview:
The global Latisse (Bimatoprost) market is expected to register a CAGR of XX.XX% during the forecast period 2018-2030. The market growth can be attributed to factors such as increasing prevalence of glaucoma, rising awareness about eye care and growing demand for cosmetic products. However, the high cost associated with the treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global Latisse (Bimatoprost) market has been segmented into below 99.5% and other segments. The below 99.5% segment is expected to account for a major share of the global Latisse (Bimatoprost) market in 2018 owing to its low price point as compared to other types available in the market. However, this segment is projected to register a lower CAGR as compared to other segments during 2018-2030 due To saturation in developed markets and increasing preference for premium products over low-priced alternatives across emerging markets. On basis if application patented product dominates Global latisse Bimatropt Market with highest share while general product are anticipated grow at faster rate over next ten years .
 Industry Outlook.svg)
Product Definition:
Latisse is a prescription eye drop used to treat hypotrichosis (a condition where you have too little hair on your eyelashes). Latisse makes your eyelashes longer, thicker, and darker.
Global Latisse (Bimatoprost) Market Size Growth Rate by Purity:
Global latisse (bimatoprost) market is expected to witness significant growth over the forecast period owing to increasing demand in various countries such as Brazil, China, India and South Africa. The growing geriatric population base coupled with rising awareness regarding hair loss treatment is anticipated to drive the global market. In addition, increasing disposable income levels along with changing lifestyles are likely to boost the product demand further.
Below 99.5%:
Below 99.5% is a concentration below which the solution will not precipitate out of solution when it is added to aqueous solutions. It has been used in pharmaceuticals and personal care products for many years, as it does not have any side effects on the human body unlike other drugs that are used to treat glaucoma and similar eye diseases.
Application Insights:
The general products segment held the largest share of over 70.0% in 2017. The growth can be attributed to the easy availability of generic drugs and low price of Bimatoprost compared with that for Latisse (Bimatoprost) manufactured by Allergan, Pfizer and Ocusync. Generalized eyelid surgery is a popular procedure performed under local anesthesia on an outpatient basis at a primary care facility or hospital outpatient department.
The patented product segment is expected to witness lucrative growth during the forecast period owing to high demand for advanced therapies resulting in high adoption rate among patients suffering from DME-DVVD or DME-TVC who have lost their vision due to cataract formation in both eyes after surgery.
Regional Analysis:
In 2017, North America dominated the global market owing to high product adoption and awareness about Latisse. The region is expected to maintain its dominance throughout the forecast period due to increasing demand for cosmetic products in countries such as U.S., Canada, and Mexico. In addition, growing number of patients suffering from alopecia are anticipated to drive regional growth over the forecast period.
Asia Pacific is expected to be one of fastest-growing regions during the forecast years due rising awareness about hair restoration treatment options among men as well as women patients in countries such China & Japan and India & Australia respectively which has led this regional market towards significant growth rate over last few years especially after launch of Bimatoprost 0.03% generic version by various manufacturers including Sun Pharmaceutical Industries Ltd., Takeda Pharmaceuticals Corporation; Dr Reddy's Laboratories Limited; WOCKHARDTGENERIC LLC; Mylan N.V.; Teva Pharmaceuticals USA Inc.
Growth Factors:
- Increasing demand for aesthetic treatments and procedures
- Growing awareness about the benefits of Latisse (Bimatoprost)
- Rising number of dermatologists recommending Latisse (Bimatoprost)
- Availability of affordable and convenient treatment options
- Growing popularity of online shopping
Scope Of The Report
Report Attributes
Report Details
Report Title
Latisse (Bimatoprost) Market Research Report
By Type
Global Latisse (Bimatoprost) Market Size Growth Rate by Purity, Below 99.5%, Other
By Application
Patented Product, General Products
By Companies
Cayman Pharma, Tecoland Corporation, TCS Group, Changzhou BOHIV, Zhejiang Ausun, Ansion Pharma, Lianmin Biochemical, Chirogate International, Everlight Chemical, GENTEC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Latisse (Bimatoprost) Market Report Segments:
The global Latisse (Bimatoprost) market is segmented on the basis of:
Types
Global Latisse (Bimatoprost) Market Size Growth Rate by Purity, Below 99.5%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Patented Product, General Products
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cayman Pharma
- Tecoland Corporation
- TCS Group
- Changzhou BOHIV
- Zhejiang Ausun
- Ansion Pharma
- Lianmin Biochemical
- Chirogate International
- Everlight Chemical
- GENTEC
 Market Overview.svg)
Highlights of The Latisse (Bimatoprost) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
- Below 99.5%
- Other
- By Application:
- Patented Product
- General Products
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Latisse (Bimatoprost) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Latisse is a prescription medication used to treat eye diseases such as glaucoma, macular degeneration, and cataracts. It is a prostaglandin E1 analog (a type of drug) that works by widening the pupil in the eye.
Some of the major companies in the latisse (bimatoprost) market are Cayman Pharma, Tecoland Corporation, TCS Group, Changzhou BOHIV, Zhejiang Ausun, Ansion Pharma, Lianmin Biochemical, Chirogate International, Everlight Chemical, GENTEC.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Latisse (Bimatoprost) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Latisse (Bimatoprost) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Latisse (Bimatoprost) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Latisse (Bimatoprost) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Latisse (Bimatoprost) Market Size & Forecast, 2018-2028
4.5.1 Latisse (Bimatoprost) Market Size and Y-o-Y Growth
4.5.2 Latisse (Bimatoprost) Market Absolute $ Opportunity
Chapter 5 Global Latisse (Bimatoprost) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Latisse (Bimatoprost) Market Size Forecast by Type
5.2.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
5.2.2 Below 99.5%
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Latisse (Bimatoprost) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Latisse (Bimatoprost) Market Size Forecast by Applications
6.2.1 Patented Product
6.2.2 General Products
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Latisse (Bimatoprost) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Latisse (Bimatoprost) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Latisse (Bimatoprost) Analysis and Forecast
9.1 Introduction
9.2 North America Latisse (Bimatoprost) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Latisse (Bimatoprost) Market Size Forecast by Type
9.6.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
9.6.2 Below 99.5%
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Latisse (Bimatoprost) Market Size Forecast by Applications
9.10.1 Patented Product
9.10.2 General Products
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Latisse (Bimatoprost) Analysis and Forecast
10.1 Introduction
10.2 Europe Latisse (Bimatoprost) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Latisse (Bimatoprost) Market Size Forecast by Type
10.6.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
10.6.2 Below 99.5%
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Latisse (Bimatoprost) Market Size Forecast by Applications
10.10.1 Patented Product
10.10.2 General Products
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Latisse (Bimatoprost) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Latisse (Bimatoprost) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Latisse (Bimatoprost) Market Size Forecast by Type
11.6.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
11.6.2 Below 99.5%
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Latisse (Bimatoprost) Market Size Forecast by Applications
11.10.1 Patented Product
11.10.2 General Products
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Latisse (Bimatoprost) Analysis and Forecast
12.1 Introduction
12.2 Latin America Latisse (Bimatoprost) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Latisse (Bimatoprost) Market Size Forecast by Type
12.6.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
12.6.2 Below 99.5%
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Latisse (Bimatoprost) Market Size Forecast by Applications
12.10.1 Patented Product
12.10.2 General Products
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Latisse (Bimatoprost) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Latisse (Bimatoprost) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Latisse (Bimatoprost) Market Size Forecast by Type
13.6.1 Global Latisse (Bimatoprost) Market Size Growth Rate by Purity
13.6.2 Below 99.5%
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Latisse (Bimatoprost) Market Size Forecast by Applications
13.10.1 Patented Product
13.10.2 General Products
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Latisse (Bimatoprost) Market: Competitive Dashboard
14.2 Global Latisse (Bimatoprost) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cayman Pharma
14.3.2 Tecoland Corporation
14.3.3 TCS Group
14.3.4 Changzhou BOHIV
14.3.5 Zhejiang Ausun
14.3.6 Ansion Pharma
14.3.7 Lianmin Biochemical
14.3.8 Chirogate International
14.3.9 Everlight Chemical
14.3.10 GENTEC
